Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos

被引:123
作者
Gapter, L
Wang, ZS
Glinski, J
Ng, KY [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Denver, CO 80262 USA
[2] Planta Analytica, Brookfield, CT 06804 USA
关键词
Akt; androgen; apoptosis; arachidonic acid; Bcl-2; carcinogenesis; caspase; PLA2; prostate cancer; triterpenoid;
D O I
10.1016/j.bbrc.2005.05.044
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pachymic acid (PA) is a natural triterpenoid known to inhibit the phospholipase A2 (PLA(2)) family of arachidonic acid (AA)producing enzymes. PLA(2) is elevated in prostatic adenocarcinoma and conversion of AA to prostaglandins leads to AKT pro-survival activity. In this study, we investigated the effect of PA on the growth of human prostate cancer cells. PA significantly reduced cell proliferation and induced apoptosis in a dose- and time-dependent fashion, with androgen-insensitive DU145 prostate cancer cells showing greater growth inhibition relative to androgen-responsive LNCaP. Despite elevated protein expression of the cell cycle inhibitor, p21, apoptosis occurred in the absence of cell cycle arrest. PA-treatment decreased Bad phosphorylation, increased Bcl-2 phosphorylation, and activated caspases-9 and -3, suggesting that PA initiated apoptosis through mitochondria dysfunction. PA-treatment also decreased the expression and activation of proteins within the AKT signal pathway. We speculate that PA influenced apoptosis by reducing prostaglandin synthesis and AKT activity. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1153 / 1161
页数:9
相关论文
共 41 条
  • [1] *AM CANC SOC, 2004, FACTS FIG 2004, P16
  • [2] Regulation and inhibition of phospholipase A2
    Balsinde, J
    Balboa, MA
    Insel, PA
    Dennis, EA
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 175 - 189
  • [3] Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells
    Böhnke, A
    Westphal, F
    Schmidt, A
    El-Awady, RA
    Dahm-Daphi, J
    [J]. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2004, 80 (01) : 53 - 63
  • [4] Programmed cell death via mitochondria: Different modes of dying
    Bras, M
    Queenan, B
    Susin, SA
    [J]. BIOCHEMISTRY-MOSCOW, 2005, 70 (02) : 231 - +
  • [5] Carson JP, 1999, CANCER RES, V59, P1449
  • [6] ARACHIDONIC-ACID METABOLISM IN BENIGN AND MALIGNANT PROSTATIC TISSUE IN-VITRO - EFFECTS OF FATTY-ACIDS AND CYCLOOXYGENASE INHIBITORS
    CHAUDRY, AA
    WAHLE, KWJ
    MCCLINTON, S
    MOFFAT, LEF
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (02) : 176 - 180
  • [7] Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer
    Chen, XF
    Thakkar, H
    Tyan, F
    Gim, S
    Robinson, H
    Lee, C
    Pandey, SK
    Nwokorie, C
    Onwudiwe, N
    Srivastava, RK
    [J]. ONCOGENE, 2001, 20 (42) : 6073 - 6083
  • [8] The BCL2 family: Regulators of the cellular life-or-death switch
    Cory, S
    Adams, JM
    [J]. NATURE REVIEWS CANCER, 2002, 2 (09) : 647 - 656
  • [9] Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
    Datta, SR
    Dudek, H
    Tao, X
    Masters, S
    Fu, HA
    Gotoh, Y
    Greenberg, ME
    [J]. CELL, 1997, 91 (02) : 231 - 241
  • [10] Davies MA, 1999, CANCER RES, V59, P2551